Captrust Financial Advisors T2 Biosystems, Inc. Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.36 - $0.57 $3 - $5	-10 Reduced 66.67%	5 $0
Q4 2021 Feb 14, 2022	BUY	$0.46 - $0.94 $6 - $14	15 New	15 $0
Q3 2021 Nov 16, 2021	SELL	$0.86 - $1.21 $258 - $363	-300 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.32 - $3.79 $396 - $1,137	300 New	300 $0

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $5.99M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.